Showing results (661-670 of 675) with videos related to
Sort By:
Pageof 68
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 2, 2001
[Intermittent administration of 5-FU and isovorin to patients with advanced and recurrent colon cancer]K Sekikawa, K Anzai, T Momma, et al.The Journal of Laboratory and Clinical Medicine|March 1, 2000
Competitive reverse transcription-polymerase chain reaction assay for quantification of human multidrug resistance 1 (MDR1) gene expression in fresh leukemic cellsH Kobayashi, Y Takemura, Y Kawai, et al.Journal of the Neurological Sciences|June 20, 2006
16q-linked autosomal dominant cerebellar ataxia: a clinical and genetic studyY Ouyang, K Sakoe, H Shimazaki, et al.Gene Therapy|February 13, 2004
Targeted conversion of the transthyretin gene in vitro and in vivoM Nakamura, Y Ando, S Nagahara, et al.Japanese Journal of Medical Science & Biology|June 1, 1996
Titration of human cytomegalovirus (HCMV) DNA in urine by combined use of PCR and microplate hybridization in a renal transplant patient with HCMV pneumonitisK Meigata, R Hondo, A Fujima, et al.Cancer Chemotherapy and Pharmacology|April 14, 2016
A phase I study of binimetinib (MEK162) in Japanese patients with advanced solid tumorsK Watanabe, S Otsu, Y Hirashima, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 20, 2009
Fixed dosing and pharmacokinetics of S-1 in Japanese cancer patients with large body surface areasK Fujita, W Ichikawa, W Yamamoto, et al.Clinical and Experimental Immunology|July 22, 2014
Successful immunotherapy of autoimmune cholangitis by adoptive transfer of forkhead box protein 3(+) regulatory T cellsH Tanaka, W Zhang, G-X Yang, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 26, 1999
Enhanced interstitial expression of caldesmon in IgA nephropathy and its suppression by glucocorticoid-heparin therapyY Ando, T Moriyama, K Oka, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 31, 2012
International models of investigator-initiated trials: implications for JapanE L Trimble, J Ledermann, K Law, et al.Pageof 68